HomeTARS • NASDAQ
add
Tarsus Pharmaceuticals Inc
Previous close
$68.90
Day range
$67.99 - $70.35
Year range
$38.51 - $85.25
Market cap
2.93B USD
Avg Volume
644.84K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 151.67M | 128.39% |
Operating expense | 130.68M | 89.31% |
Net income | -8.37M | 63.77% |
Net profit margin | -5.52 | 84.14% |
Earnings per share | -0.20 | 66.67% |
EBITDA | -7.53M | 68.60% |
Effective tax rate | -32.61% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 417.27M | 43.21% |
Total assets | 562.16M | 49.12% |
Total liabilities | 218.73M | 43.47% |
Total equity | 343.43M | — |
Shares outstanding | 42.56M | — |
Price to book | 8.54 | — |
Return on assets | -3.64% | — |
Return on capital | -4.72% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -8.37M | 63.77% |
Cash from operations | 19.33M | 187.14% |
Cash from investing | 49.27M | 182.71% |
Cash from financing | 2.31M | -21.01% |
Net change in cash | 70.92M | 189.96% |
Free cash flow | 15.26M | 163.06% |
About
Founded
2016
Headquarters
Website
Employees
370
